Table 1. Intracellular retinoic acid concentrations following incubation with or without 50 μM acitretin for 24 h prior to the addition of 10 μM ATRA or 13cisRA for a further 24 ha.
ATRA incubation (μM)
|
13cisRA incubation (μM)
|
||||||
---|---|---|---|---|---|---|---|
Cell line | RA isomer | Control | Acitretin | P b | Control | Acitretin | P b |
SH-SY5Y | ATRA | 39.1±7.4 | 113.5±28.7 | 0.003 | 4.2±1.1 | 19.3±4.1 | 0.005 |
13cisRA | 7.6±1.3 | 7.5±0.7 | 0.744 | 25.4±4.1 | 28.7±6.9 | 0.674 | |
SH-EP | ATRA | 908.1±378 | 1050±439.3 | 0.652 | 49.9±10.6 | 51.9±18.2 | 0.933 |
13cisRA | 43.5±9.1 | 39.9±11.3 | 0.886 | 92.7±19.7 | 75.7±29.1 | 0.435 | |
IMR-32 | ATRA | 354.6±31.6 | 447.9±83.6 | 0.382 | 59.9±31.1 | 120.2±66.2 | 0.707 |
13cisRA | 29.7±2.5 | 26.5±1.6 | 0.352 | 39.4±17.3 | 60.4±14.6 | 0.378 | |
NGP | ATRA | 613.3±165.3 | 1657±688.3 | 0.083 | 32.5±15.2 | 21.4±1.4 | 0.642 |
13cisRA | 46.0±11.7 | 67.2±23.4 | 0.41 | 84.6±11.4 | 106.9±7.7 | 0.221 |
Results are expressed as mean±s.e.m. from n⩾3 experiments.
Probabilities from two-sided t-tests.